Skip to content
OpenCapital
Get started

HealthEquity HQY Sales & Marketing

Sales & Marketing at other companies

Webster Financial Corporation logo
Webster Financial CorporationWBS
$4.7M+16.7%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's sales & marketing?
HealthEquity (HQY) reported sales & marketing of $26.83M in Q1 2026.
How has HealthEquity's sales & marketing changed year-over-year?
HealthEquity's sales & marketing increased by 3.3% year-over-year, from $25.98M to $26.83M.
What is the long-term trend for HealthEquity's sales & marketing?
Over 4 years (2022 to 2026), HealthEquity's sales & marketing has grown at a 12.9% compound annual growth rate (CAGR), from $58.61M to $95.24M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.